Proton magnetic resonance spectroscopic imaging of cerebral gliomas: Correlation of metabolite ratios with histopathologic grading

Chang Gung Medical Journal

Volumn 27, Issue 6, 2004, Pages 399-407

  Hsu, Yuan Yu ^a   Chang, Chen Nen ^a   Wie, Kuo Jen ^a   Lim, Kun Eng ^a   Hsu, Wen Chin ^a   Jung, Shih Ming ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Brain; Glioma; Proton MR spectroscopy

Indexed keywords

CHOLINE DERIVATIVE; CREATINE; CREATINE PHOSPHATE; LACTIC ACID; N ACETYLASPARTIC ACID;

ADULT; AGED; ARTICLE; CANCER GRADING; CLINICAL ARTICLE; CORRELATION ANALYSIS; DISEASE SEVERITY; EVALUATION; FEMALE; GLIOMA; HISTOPATHOLOGY; HUMAN; LACTATE BLOOD LEVEL; MALE; METABOLITE; PROTON NUCLEAR MAGNETIC RESONANCE; STATISTICAL SIGNIFICANCE; TISSUE SPECIFICITY; WORLD HEALTH ORGANIZATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; FEMALE; GLIOMA; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED;

EID: 4043074825     PISSN: 02558270     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Felix R, Schomer W, Laniado M, Niendorf HP, Claussen C, Fiegler W, Speck U. Brain tumors: MR imaging with gadolinium-DTPA. Radiology 1985;156:681-8.
2. Brant-Zawadzki M, Berry I, Osaki L, Brasch R, Murovic J, Norman D. Gd-DTPA in clinical MR of the brain: intraaxial lesions. AJNR Am J Neuroradiol 1986;8:781-8.
3. Krouwer HG, Kim TA, Rand SD, Prost RW, Haughton VM, Hok C, Jaradeh SS, Meyer GA, Blindauer KA, Cusick JF, Morris GL, Walsh PK. Single-voxel proton MR spectroscopy of nonneoplastic brain lesions suggestive of a neoplasm. AJNR Am J Neuroradiol 1998;19:1695-703.
4. Bendszus M, Wamuth-Metz M, Klein R, Burger R, Schichor C, Tonn JC, Solymosi L. MR spectroscopy in gliomatosis cerebri. AJNR Am J Neuroradiol 2000;21:375-80.
5. Tien RD, Lai PH, Smith JS, Lazeyras F. Single voxel proton brain spectroscopy exam (PROBE/SV) in patients with primary brain tumors. AJNR Am J Roentgenol 1996;167:201-9.
6. Meyerand ME, Pipas JM, Mamourian A, Tosteson TD, Dunn JF. Classification of biopsy-confirmed brain tumors using single-voxel MR spectroscopy. AJNR Am J Neuroradiol 1999;20:117-23.
7. Urenjak J, Williams SR, Gadian DG, Noble M. Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types. J Neurosci 1993;13:981-9.
8. Miller BL. A review of chemical issues in H1 NMR spectroscopy: N-acetylaspartate, creatine and choline. NMR Biomed 1991;4:47-52.
9. Cousins JP. Clinical MR spectroscopy: fundamentals, current applications, and future potential. AJNR Am J Roentgenol 1995;164:1337-47.
10. Castillo M, Kwock L. Clinical application of proton magnetic resonance spectroscopy in the evaluation of common intracranial tumors. Topic Magn Reson Imag 1999;10:104-13.
11. Hsu YY, Chen MC, Lim KE, Chang C. Reproducibility of hippocampal single-voxel proton MR spectroscopy and chemical shift imaging. AJNR Am J Roentgenol 2001;176:529-36.
12. Poptani H, Gupta RK, Roy R, Pandey R, Jain VK, Chhabra DK. Characterization of intracranial mass lesions with in vivo proton MR spectroscopy. AJNR Am J Neuroradiol 1995;16:1593-603.
13. Moller-Hartmann W, Herminghaus S, Krings T, Marquardt, Lanfermann H, Pilatus U, Zanella FE. Clinical application of proton magnetic resonance spectroscopy in the diagnosis of intracranial mass lesions. Neuroradiology 2002;44:371-81.
14. Henriksen O. In vivo quantitation of metabolite concentrations in the brain by means of proton MRS. NMR Biomed 1995;8:139-48.
15. Negendank WG, Sauter R, Brown TR, Evelhoch JL, Falini A, Gotsis ED, Heerschap A, Kamada K, Lee BCP, Mengeot MM, Moser E, Padavic-Shaller KA, Sanders JA, Spraggins TA, Stillman AE, Terwey B, Vogl TJ, Wicklow K, Zimmerman RA. Proton magnetic resonance spectroscopy in patients with glial tumors: a multicenter study. J Neurosurg 1996;84:449-58.
16. Schlemmer HP, Bachert P, Herfarth KK, Zuna I, Debus J, van Kaick G. Proton MR spectroscopic evaluation of suspicious brain lesions after stereotactic radiotherapy. AJNR Am J Neuroradiol 2001;22:1316-24.
17. Ott D, Hennig J, Ernst T. Human brain tumors: assessment with in vivo proton MR spectroscopy. Radiology 1993;186:745-52.
18. Burtscher IM, Skagerberg G, Geijer B, Englund E, Stahlberg F, Holtas S. Proton MR spectroscopy and preoperative diagnostic accuracy: an evaluation of intracranial mass lesions characterized by stereotactic biopsy findings. AJNR Am J Neuroradiol 2000;21:84-93.
19. Bulakbasi N, Kocaoglu M, Ors F, Tayfun C, Ucoz T. Combination of single-voxel proton MR spectroscopy and apparent diffusion coefficient calculation in the evaluation of common brain tumors. AJNR Am J Neuroradiol 2003;24:225-33.
20. Haase A, Frahm J, Hanike W, Matthae D. 1H NMR chemical shift selective (CHESS) imaging. Phys Med Biol 1985;30:341-344.
21. Silberstein M. H-1 MR spectroscopy in differentiation of brain abscess and brain tumor. Radiology 1997;204:239-45.
22. Kleihues P, Cavenee WK (editors). World Health Organization classification of tumours: pathology and genetics of tumours of the nervous system. Lyon, France: International Agency for Research on Cancer, 2000.
23. Burtscher IM, Skagerberg G, Geijer B, Englund E, Stahlberg F, Holtas S. Proton MR spectroscopy and preoperative diagnostic accuracy: an evaluation of intracranial mass lesions characterized by stereotactic biopsy findings. AJNR Am J Neuroradiol 2000;21:84-93.
24. Fulham MJ, Bizzi A, Dietz MJ, Shih HHL, Raman R, Sobering GS, Frank JA, Dwyer AJ, Alger JR, Di Chiro G. Mapping of brain tumor metabolites with proton MR spectroscopic imaging: clinical relevance. Radiology 1992;185:675-86.
25. Burger PC, Scheithauer BW, Vogel FS. The brain-tumors. In: Burger PC, Scheithauer BW, Vogel FS, eds. Surgical pathology of the nervous system and its coverings. 4th ed. Philadelphia: Churchill Livingstone Co., 2002:160-378.
26. Sutton LN, Wang Z, Gusnard D, Lange B, Perilongo G, Bogdan AR, Detre JA, Rorke L, Zimmer man RA. Proton magnetic resonance spectroscopy of pediatric brain tumors. Neurosurgery 1992;31:195-202.
27. Shimizu H, Kumabe T, Shirane R, Yoshimoto T. Correlation between choline level measured by proton MR spectroscopy and Ki-67 labeling index in gliomas. AJNR Am J Neuroradiol 2000;21:659-65.
28. Nelson SJ, Vigneron DB, Dillon WP. Serial evaluation of patients with brain tumors using volume MRI and 3DiH MRSI. NMR Biomed 1999;12:123-38.
29. Kuesel AC, Sutherland GR, Halliday W, Smith IC. 1H MR spectroscopy of high grade astrocytoma: mobile lipid accumulation in necrotic tissue. NMR Biomed 1994;7:149-55.
30. Segebarth CM, Baleriaux DF, Luyten PR, Den Hollander JA. Detection of metabolic heterogeneity of human intracranial tumors in vivo by 1H NMR spectroscopic imaging. Magn Reson Med 1990;13:62-76.
31. Herholz K, Heindel W, Luyten PR, den Hollander JA, Pietrzyk U, Voges J, Kugel H, Friedmann G, Heiss WD. In vivo imaging of glucose consumption and lactate concentration in human gliomas. Ann Neurol 1992;31:319-27.
32. Castillo M, Smith JK, Kwock L. Correlation of Myo-inositol levels and grading of cerebral astrocytomas. AJNR Am J Neuroradiol 2000;21:1645-9.